Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment

Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment

US Patent 11020478 · Granted Jun 1, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant chorionic gonadotropin, procedure for preparation, pharmaceutical co2025
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatm2023
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatm2023
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatm2023
Therapeutic modulation of skin immune system with Gal-72019
Therapeutic modulation of skin immune system with Gal-72019
Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatme2019
Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatme2019
Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatme2019
Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment2019
Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment2019
Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment2019